HAVRIX

Biological GlaxoSmithKline, LLC.
Total Payments
$59,309
Transactions
70
Doctors
58
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2020 $41,564 27 18
2019 $52.82 4 4
2018 $17,211 8 5
2017 $482.00 31 31

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $49,980 11 84.3%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $8,679 16 14.6%
Food and Beverage $650.58 43 1.1%

Payments by Type

Research
$49,980
11 transactions
General
$9,329
59 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
MMR-160 GlaxoSmithKline, LLC. $49,980 0

Top Doctors Receiving Payments for HAVRIX — Page 2

Doctor Specialty Location Total Records
, M.D Obstetrics & Gynecology Los Angeles, CA $18.10 1
, M.D Family Medicine Los Angeles, CA $18.10 1
, M.D Internal Medicine Atlanta, GA $16.54 1
, MD Internal Medicine Atlanta, GA $16.54 1
, M.D Internal Medicine Atlanta, GA $16.54 1
, MD Internal Medicine Atlanta, GA $16.54 1
, M.D Internal Medicine Atlanta, GA $16.54 1
, M.D Internal Medicine Atlanta, GA $16.54 1
, M.D Internal Medicine Atlanta, GA $16.54 1
, M.D Family Medicine Alexandria, KY $16.42 1
, M.D Family Medicine Alexandria, KY $16.42 1
, MD Family Medicine Columbus, GA $15.90 1
, D.O Internal Medicine El Paso, TX $15.42 1
, MD Pediatrics Bristol, TN $14.82 1
, DO Internal Medicine New Kensington, PA $14.72 1
, MD Internal Medicine Millsboro, DE $13.90 1
, MD Family Medicine Wilmington, DE $12.89 1
, MD General Practice Wilmington, DE $12.89 1
, MD General Practice Wilmington, DE $12.89 1
, MD Family Medicine Wilmington, DE $12.89 1
, MD General Practice Wilmington, DE $12.89 1
, MD Internal Medicine New Kensington, PA $12.59 1
, MD Internal Medicine New Kensington, PA $12.59 1
, D.O Adolescent Medicine Joplin, MO $12.55 1
, MD Internal Medicine Greenfield, IN $12.33 1

About HAVRIX

HAVRIX is a biological associated with $59,309 in payments to 58 healthcare providers, recorded across 70 transactions in the CMS Open Payments database. The primary manufacturer is GlaxoSmithKline, LLC..

Payment data is available from 2017 to 2020. In 2020, $41,564 was paid across 27 transactions to 18 doctors.

The most common payment nature for HAVRIX is "Unspecified" ($49,980, 84.3% of total).

HAVRIX is associated with 1 research study, including "MMR-160" ($49,980).